GLOBAL PERSPECTIVES ON EARLY-STAGE INVESTMENT & PARTNERING
With over 130 Life Sciences entrepreneurs, innovators, investors and strategists in attendance, the Global Perspectives on Early-Stage Investment and Partnering summit, hosted by Novateur Ventures and Accel-Rx was recognized as a “first of its kind” event held in Vancouver.
In the midst of the beautiful VanDusen Botanical Gardens, 6 expert panelists from leading Pharma and Venture Capitals, from across the US, Europe and China discussed topics pertaining to how life sciences start-ups and early-stage innovators should structure themselves to partner with big pharma or seek funding from venture capitals.
Natalie Dakers, Founding President and Chief Executive Officer of Accel-Rx and Ali Ardakani, Founder & Managing Director of Novateur Ventures, gave welcoming remarks at the Global Perspectives on Early-Stage Investment & Partnering event on Oct 3, 2018.
Ali Ardakani, Founder & Managing Director of Novateur was moderating the panel Demystifying Chinese Venture Capital; A US Perspective on the Current Climate for Investments & IPOs.